CSNpharm
Donepezil HCl is a selective and reversible AchE inhibitor, highly selective for the central nervous system and used in the management of mild to moderate Alzheimer’s disease and dementia.
More Information
Supplier Page
CSNpharm
Donepezil HCl is a selective and reversible AchE inhibitor, highly selective for the central nervous system and used in the management of mild to moderate Alzheimer’s disease and dementia.
More Information
Supplier Page
CSNpharm
Donepezil HCl is a selective and reversible AchE inhibitor, highly selective for the central nervous system and used in the management of mild to moderate Alzheimer’s disease and dementia.
More Information
Supplier Page
CSNpharm
Donepezil HCl is a selective and reversible AchE inhibitor, highly selective for the central nervous system and used in the management of mild to moderate Alzheimer’s disease and dementia.
More Information
Supplier Page
CSNpharm
Doramapimod is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC, PKCα/β/γ.
More Information
Supplier Page
CSNpharm
Doramapimod is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC, PKCα/β/γ.
More Information
Supplier Page
CSNpharm
Doramapimod is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC, PKCα/β/γ.
More Information
Supplier Page
CSNpharm
Doramapimod is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC, PKCα/β/γ.
More Information
Supplier Page
CSNpharm
Doramapimod is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC, PKCα/β/γ.
More Information
Supplier Page
CSNpharm
Doramapimod is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC, PKCα/β/γ.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Doripenem is a member of the carbapenem class of beta-lactam antibiotics with broad-spectrum coverage of Gram-positive, Gram-negative and anaerobic pathogens.
More Information
Supplier Page
CSNpharm
Doripenem is a member of the carbapenem class of beta-lactam antibiotics with broad-spectrum coverage of Gram-positive, Gram-negative and anaerobic pathogens.
More Information
Supplier Page
CSNpharm
Doripenem is a member of the carbapenem class of beta-lactam antibiotics with broad-spectrum coverage of Gram-positive, Gram-negative and anaerobic pathogens.
More Information
Supplier Page
CSNpharm
Doripenem Hydrate is an ultra-broad spectrum carbapenem derivative antibacterial agent used to treat complicated urinary infection including Pyelonephritis caused by E.coli.
More Information
Supplier Page
CSNpharm
Doripenem Hydrate is an ultra-broad spectrum carbapenem derivative antibacterial agent used to treat complicated urinary infection including Pyelonephritis caused by E.coli.
More Information
Supplier Page
CSNpharm
Doripenem Hydrate is an ultra-broad spectrum carbapenem derivative antibacterial agent used to treat complicated urinary infection including Pyelonephritis caused by E.coli.
More Information
Supplier Page
CSNpharm
Dorzolomide HCl is a potent and water-soluble inhibitor of human carbonic anhydrase II and IV with Ki of 1.9 nM and 31 nM respectively and used as anti-glaucoma agent.
More Information
Supplier Page
CSNpharm
Dorzolomide HCl is a potent and water-soluble inhibitor of human carbonic anhydrase II and IV with Ki of 1.9 nM and 31 nM respectively and used as anti-glaucoma agent.
More Information
Supplier Page
CSNpharm
Dorzolomide HCl is a potent and water-soluble inhibitor of human carbonic anhydrase II and IV with Ki of 1.9 nM and 31 nM respectively and used as anti-glaucoma agent.
More Information
Supplier Page
CSNpharm
Doxapram inhibits TASK-1, TASK-3, TASK-1/TASK-3 heterodimeric channel function with EC50 of 410 nM, 37 μM, 9 μM, respectively.
More Information
Supplier Page
CSNpharm
Doxapram inhibits TASK-1, TASK-3, TASK-1/TASK-3 heterodimeric channel function with EC50 of 410 nM, 37 μM, 9 μM, respectively.
More Information
Supplier Page
CSNpharm
Doxapram HCl, a respiratory stimulant, exhibits inhibition of TASK-1 (EC50 = 410 nM), TASK-3 (EC50 = 37 nM) and TASK-1/TASK-3 heterodimeric (EC50 = 9 nM) channel function. It is widely used in central nervous system excitability and directly stimulate the medullary respiratory or vascular movement center.
More Information
Supplier Page
CSNpharm
Doxapram HCl, a respiratory stimulant, exhibits inhibition of TASK-1 (EC50 = 410 nM), TASK-3 (EC50 = 37 nM) and TASK-1/TASK-3 heterodimeric (EC50 = 9 nM) channel function. It is widely used in central nervous system excitability and directly stimulate the medullary respiratory or vascular movement center.
More Information
Supplier Page
CSNpharm
Doxapram HCl, a respiratory stimulant, exhibits inhibition of TASK-1 (EC50 = 410 nM), TASK-3 (EC50 = 37 nM) and TASK-1/TASK-3 heterodimeric (EC50 = 9 nM) channel function. It is widely used in central nervous system excitability and directly stimulate the medullary respiratory or vascular movement center.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Doxazosin mesylate is a selective α1-adrenergic receptor blocker, used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia (BPH).
More Information
Supplier Page
CSNpharm
Doxazosin mesylate is a selective α1-adrenergic receptor blocker, used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia (BPH).
More Information
Supplier Page
CSNpharm
Doxazosin mesylate is a selective α1-adrenergic receptor blocker, used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia (BPH).
More Information
Supplier Page
CSNpharm
Doxepin HCl, a tricyclic antidepressant, is antagonist of histamine H1 Receptor (Kd = 310 pM) and histamine H4 receptor (pKi = 6.79). It can be used to treat chronic idiopathic urticaria.
More Information
Supplier Page
CSNpharm
Doxepin HCl, a tricyclic antidepressant, is antagonist of histamine H1 Receptor (Kd = 310 pM) and histamine H4 receptor (pKi = 6.79). It can be used to treat chronic idiopathic urticaria.
More Information
Supplier Page
CSNpharm
Doxercalciferol is a synthetic vitamin D2 analog, suppressing parathyroid synthesis and secretion, used to treat secondary hyperparathyroidism and metabolic bone disease.
More Information
Supplier Page
CSNpharm
Doxercalciferol is a synthetic vitamin D2 analog, suppressing parathyroid synthesis and secretion, used to treat secondary hyperparathyroidism and metabolic bone disease.
More Information
Supplier Page
CSNpharm
Doxercalciferol is a synthetic vitamin D2 analog, suppressing parathyroid synthesis and secretion, used to treat secondary hyperparathyroidism and metabolic bone disease.
More Information
Supplier Page
CSNpharm
Doxercalciferol is a synthetic vitamin D2 analog, suppressing parathyroid synthesis and secretion, used to treat secondary hyperparathyroidism and metabolic bone disease.
More Information
Supplier Page
CSNpharm
Doxercalciferol is a synthetic vitamin D2 analog, suppressing parathyroid synthesis and secretion, used to treat secondary hyperparathyroidism and metabolic bone disease.
More Information
Supplier Page
CSNpharm
Doxercalciferol is a synthetic vitamin D2 analog, suppressing parathyroid synthesis and secretion, used to treat secondary hyperparathyroidism and metabolic bone disease.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Doxorubicin HCl is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis in tumor cells.
More Information
Supplier Page
CSNpharm
Doxorubicin HCl is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis in tumor cells.
More Information
Supplier Page
CSNpharm
Doxorubicin HCl is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis in tumor cells.
More Information
Supplier Page
CSNpharm
Doxycycline HCl is a broad-spectrum antibiotic used to treat infections caused by bacteria, including pneumonia and other respiratory tract infections, and an MMP inhibitor.
More Information
Supplier Page
CSNpharm
Doxylamine Succinate Salt is an antihistamine which inhibits histamine H1 receptors. It can be used as a short-term sedative and anticholinergic agent.
More Information
Supplier Page
CSNpharm
Doxylamine Succinate Salt is an antihistamine which inhibits histamine H1 receptors. It can be used as a short-term sedative and anticholinergic agent.
More Information
Supplier Page
Dp44mT
100mg
| ≥98%
CSNpharm
